"MyoKardia is an important company because they developed a really interesting approach to the treatment of cardiovascular disease," Bristol-Myers Squibb CEO Giovanni Caforio said.
from Business News https://ift.tt/3jFNraY
via IFTTT
Monday, October 5, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment